Literature DB >> 25486002

The modified ilioinguinal and anterior intrapelvic approaches for acetabular fracture fixation: indications, quality of reduction, and early outcome.

Tim J S Chesser1, Will Eardley, Andrew Mattin, Amy M Lindh, Mehool Acharya, Anthony J Ward.   

Abstract

OBJECTIVES: Traditionally, the anterior surgical approach of choice for acetabular reconstruction was ilioinguinal. There has been an increasing usage of the midline "Stoppa" or "anterior intrapelvic approach." The aim is to report the techniques, early results (minimum 1 year), and complications of anterior approaches for acetabular reconstruction.
DESIGN: Retrospective case-note review.
SETTING: Pelvic and acetabular tertiary center. PATIENTS: A consecutive series of acetabular fractures treated at 1 tertiary specialist unit were retrospectively reviewed. The fracture patterns, incisions used, intraoperative and postoperative complications, reduction achieved (measured on postoperative radiographs and computed tomography scans), and early postoperative results (minimum 1-year follow-up), were recorded. MAIN OUTCOME MEASUREMENTS: Postoperative reduction (measured by postoperative plain radiographs and computed tomography).
RESULTS: Of 160 consecutive patients who underwent acetabular reconstruction, 56 (mean age, 44 years) underwent reconstruction using only anterior approaches (mean of 7 days after injury). Iatrogenic complications, postoperative infection, arthritis, and avascular necrosis rates are comparable with the literature. Overall, anatomic reduction was seen in 71% of cases and concentric reconstruction of the dome in over 90%. Thirty-six of the 56 patients (64%) were symptom-free at the latest follow-up and 34 (61%) had returned to work.
CONCLUSIONS: The results reported suggest the use of dual approaches using the lateral 2 windows, and/or a midline anterior intrapelvic approach in anterior acetabular reconstructions has a relatively low complication rate and can lead to anatomic reconstructions in 71%. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2015        PMID: 25486002     DOI: 10.1097/BOT.0000000000000268

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  6 in total

1.  Acute intrapelvic cup migration: advantages of adyuvant Stoppa approach for implant removal/reconstruction. A case report.

Authors:  Antonio Murcia-Asensio; Francisco Ferrero-Manzanal; Raquel Lax-Pérez; Miguel Angel Suárez-Suárez; Emilio José Salmerón-Martínez
Journal:  J Orthop       Date:  2017-05-20

Review 2.  Acetabular fractures treatment needs in the elderly and nonagenarians.

Authors:  Julia Riemenschneider; Jan Tilmann Vollrath; Nils Mühlenfeld; Johannes Frank; Ingo Marzi; Maren Janko
Journal:  EFORT Open Rev       Date:  2022-05-31

3.  Oblique-ilioischial plate technique: a novel method for acetabular fractures involving low posterior column.

Authors:  Zhong Chen; Zhao-Xiang Wu; Ge Chen; Yi Ou; Hong-Jie Wen
Journal:  BMC Musculoskelet Disord       Date:  2022-06-06       Impact factor: 2.562

4.  The influence of bone quality on radiological outcome in 50 consecutive acetabular fractures treated with a pre-contoured anatomic suprapectineal plate.

Authors:  Maximilian J Hartel; Tareq Naji; Florian Fensky; Frank O Henes; Darius M Thiesen; Wolfgang Lehmann; Karl-Heinz Frosch; Dimitris Ntalos
Journal:  Arch Orthop Trauma Surg       Date:  2021-03-24       Impact factor: 2.928

Review 5.  Anatomical quadrilateral plate for acetabulum fractures involving quadrilateral surface: A review.

Authors:  Ramesh K Sen; Gaurav Saini; Sagar Kadam; Neha Raman
Journal:  J Clin Orthop Trauma       Date:  2020-10-17

6.  Does use of a quadrilateral surface plate improve outcome in elderly acetabular fractures?

Authors:  Graeme Nicol; Ethan Sanders; Allan Liew; Geoffrey Wilkin; Wade T Gofton; Steven Papp; George Grammatopoulos
Journal:  J Clin Orthop Trauma       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.